ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc (LCTX)

0.5758
-0.023
( -3.84% )
Updated: 10:53:31

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 123.66M113.21M111.69M106.15M101.02M108.48M102.8M96.59M
Total Current Assets 60M49.66M48.49M43.48M38.44M45.72M40.39M34.4M
Cash and Equivalents 11.36M15.45M33.89M31.47M35.44M43.58M29.62M27.75M
Total Non-Current Assets 69.34M69.13M68.51M67.53M67.35M64.87M64.43M64.21M
Total Liabilities 51.73M44.19M40.43M39.49M39M37.49M35.93M31.8M
Total Current Liabilities 18.98M17.23M16.05M15.88M17.96M16.89M15.28M13.86M
Total Non-Current Liabilities 32.83M27.1M24.49M23.71M21.13M20.68M20.72M18.02M
Common Equity 440.28M441.3M448.25M450.28M451.34M466.57M467.93M469.27M
Retained Earnings -363.37M-367.74M-372.97M-380.08M-384.86M-391.4M-397.16M-2.89M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 142.57M173.24M101.66M125.48M107.95M174.55M123.66M101.02M
Total Current Assets 25.65M42.62M36.36M57.52M44M111.55M60M38.44M
Cash and Equivalents 22.09M36.84M23.59M9.5M32.59M55.74M11.36M35.44M
Total Non-Current Assets 130.51M164.26M92.25M111.25M95.13M90.9M71.94M62.02M
Total Liabilities 12.06M8.98M9.41M14.23M12.82M83.65M51.73M39M
Total Current Liabilities 8.85M6.88M6.81M6.49M7.77M47.12M18.98M17.96M
Total Non-Current Liabilities 6.06M3.27M4.56M7.81M5.08M36.56M32.83M21.13M
Total Equity 130.51M164.26M92.25M111.25M95.13M90.9M71.94M62.02M
Common Equity 317.88M378.49M354.27M387.06M393.94M434.53M440.28M451.34M
Retained Earnings -196.32M-216.3M-261.86M-273.42M-294.08M-337.1M-363.37M-384.86M

Your Recent History

Delayed Upgrade Clock